Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma

被引：37
|
作者：
Dummer, Reinhard [1 ]
Guggenheim, Merlin [2 ]
Arnold, Andres W. [3 ]
Braun, Ralph [1 ]
von Moos, Roger [4 ]
机构：
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland
[3] Unvers Hosp Basel, Dept Dermatol, Basel, Switzerland
[4] Kantonsspital Graubunden, Div Oncol, Graubunden, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2011年 / 141卷
关键词：
melanoma; guidelines; staging; therapy; follow-up; RANDOMIZED PHASE-III; SENTINEL-NODE BIOPSY; MALIGNANT-MELANOMA; RADIATION TREATMENT; TUMOR BURDEN; STAGE-III; SURVIVAL; DACARBAZINE; LYMPHADENECTOMY; BIOCHEMOTHERAPY;
D O I：
10.4414/smw.2011.13320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Melanoma is the most common lethal cutaneous neoplasm. In order to harmonise treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006. A new classification and recent results in randomised trials necessitated changes concerning staging and modifications of the recommendations of therapy and follow-up.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Willemze, R.
    Dreyling, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v177 - v180
  • [32] Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Willemze, R.
    Hodak, E.
    Zinzani, P. L.
    Specht, L.
    Ladetto, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 30 - 40
  • [33] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
    Jost, LM
    Jelic, S
    Purkalne, G
    ANNALS OF ONCOLOGY, 2005, 16 : 66 - 68
  • [34] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
    Jost, LM
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1012 - 1013
  • [35] Prospective evaluation of a follow-up schedule in cutaneous melanoma patients:: Recommendations for an effective follow-up strategy
    Garbe, C
    Paul, A
    Kohler-Späth, H
    Ellwanger, U
    Stroebel, W
    Schwarz, M
    Schlagenhauff, B
    Meier, F
    Schittek, B
    Blaheta, HJ
    Blum, A
    Rassner, G
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) : 520 - 529
  • [36] Costs of the detection of metastases and follow-up examinations in cutaneous melanoma
    Leiter, Ulrike
    Marghoob, Ashfaq A.
    Lasithiotakis, Konstantinos
    Eigentler, Thomas K.
    Meier, Friedegund
    Meisner, Christoph
    Garbe, Claus
    MELANOMA RESEARCH, 2009, 19 (01) : 50 - 57
  • [37] Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma - Part I
    Martins Castro, Luiz Guilherme
    Messina, Maria Cristina
    Loureiro, Walter
    Macarenco, Ricardo Silvestre
    Duprat Neto, Joao Pedreira
    Bello Di Giacomo, Thais Helena
    Bittencourt, Flavia Vasques
    Bakos, Renato Marchiori
    Serpa, Sergio Schrader
    Stolf, Hamilton Ometto
    Gontijo, Gabriel
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (06) : 851 - 861
  • [38] Standards, options and recommendations: Clinical practice guidelines for diagnosis, treatment and follow up in cutaneous melanoma (cm)
    Negrier, S
    Fervers, B
    Bailly, C
    Beckendorf, V
    Dore, J
    Dorval, T
    Garbay, J
    Vilmer, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S372 - S372
  • [39] Follow-up of Melanoma
    Ikizoglu, Guliz
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2007, 41 : 22 - 25
  • [40] Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines
    Anne Brecht Francken
    Helen M. Shaw
    Neil A. Accortt
    Seng-Jaw Soong
    Harald J. Hoekstra
    John F. Thompson
    Annals of Surgical Oncology, 2007, 14 : 1924 - 1933
12345